News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
Multiyear Agreement Extends Pharmacopeia's Largest Collaboration to Identify and Optimize New Drug Candidates
05-Sep-2003 - Pharmacopeia, Inc. announced a new drug discovery collaboration with Schering-Plough Corporation, continuing Pharmacopeia's research relationship with Schering-Plough for a minimum of three additional years. Pharmacopeia and Schering-Plough began their relationship in 1994, initially focusing ...
22-Aug-2003 - Merck Electronic Chemicals Holding GmbH of Germany recently signed a cooperation agreement with Moses Lake Industries (MLI) of Moses Lake, Washington, USA. Both companies agree to actively market the products of the partner in their respective territories. Merck Electronic Chemicals Holding ...
21-Aug-2003 - Merck KGaA announced that Merck CHC Holding, its wholly owned Consumer Health Care business, has acquired Peter Black Direct Marketing Ltd., a U.K.-based direct marketer of vitamins, minerals and supplements, in order to expand and reinforce Merck's market share in Great Britain. Peter Black ...
12-Aug-2003 - Merck KGaA announced today that EMD Biosciences, Inc., its United States life sciences subsidiary located in San Diego, CA, has acquired ProteoPlex, Inc. of St. Louis, MO, privately owned research and development company specializing in functional genomics and proteomics. ProteoPlex will be a ...
04-Aug-2003 - ICN Pharmaceuticals, Inc. announced that it received a decision in its arbitration case between ICN and its 80-percent owned subsidiary, Ribapharm Inc. and Schering-Plough Corporation. The arbitration dispute was related to royalties on ribavirin sales that were part of Schering's indigent care ...
Pre-clinical research in France to be concentrated in Chilly-Mazarin
11-Jul-2003 - Merck KGaA announced today that it has decided to launch a project to restructure its pharmaceutical activities in France, including the closure of its Lacassagne research and development (R&D) and production site in Lyon. The project has been presented to employee representatives, local ...
02-Jun-2003 - In a strategic move to focus clinical development resources even more strongly on its Oncology pipeline, Merck KGaA announced today that the company has decided to discontinue further development of two early-stage Diabetes projects. The decision involves EML 16336, an insulin mimetic that ...
26-May-2003 - Merck KGaA today announced that it has entered into a Marketing, Distribution, Trademark and Supply Agreement with Nippon Shinyaku Co., Ltd. of Kyoto, Japan, for the Japanese rights to acamprosate (Campral®) in the treatment of alcohol dependence. The agreement covers the development, marketing ...
06-May-2003 - Darmstadt, Germany - Merck KGaA announced today that it has sold its Nutriblend Ltd. nutritional supplements business to LycoRed Natural Products Industries Ltd. Terms of the agreement were not disclosed. The divestiture includes two business lines: the nutritional systems business of ...
02-May-2003 - Epimmune Inc. today announced that it had entered into an Agreement with Merck & Co., Inc. under which Merck will evaluate select Epimmune epitopes in connection with technology controlled by Merck for the development of certain vaccines. Under the terms of the Agreement, Epimmune will provide ...
© 1997-2024 LUMITOS AG, All rights reserved